IOIBD
INTERNATIONAL ORGANIZATION FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE
2007 Annual General Meeting - Itinerary
Final Program
IOIBD Annual Meeting 2007
April 19th April 22nd
Hotel Palacio de los Velada
Avila, Spain
Thursday, April 19th
14:00 18:00 Arrival of members / registration
16:00 18:00 Executive Committee Meeting I (Salon Renacimiento)
18:00 20:00 Annual
General Business Meeting (Salon Tietar)
Presentation of new members
(20 + 5)
"Modulation of the immune system by
muramyl dipeptide"
S. Gosh P
"Cancer surveillance in ulcerative
colitis the way forward"
M. Kamm P
20:00 Welcome cocktail (Patio) and dinner (Salon Primavera)
Friday, April 20th
06:30 08:00 Breakfast (breakfast for partners and guests until 09.00)
09:00- 13:00 Social program for partners and guests (visit to visiting center& archeological site of pre-roman villages at 30min by bus from Avila)
08:00 Start of Annual Meeting (Salon Tietar)
08:00 09:40
Presentation of new members (20 +
5) "Risk, benefit and patient
preferences in biologic therapy"
B. Sands P
"Cytokines in inflammatory bowel
disease" M. Neurath
P
"Validating outcomes in clinical
trials in ulcerative colitis"
S. Travis P
"IBD in Eastern Europe: from
epidemiology to genetics"
P. Lakatos P
09:40 10:10 Coffee break
10:10 11:50 Local
presentations (15 +
5)
Moderators: J.F. Colombel
P / A.S. Pena
P
"Advances in double balloon enteroscopy. An experimental
model and applications in Crohn's disease."
E. Perez-Cuadrado,
Murcia P
"Stem cells from abdominal fat in treating fistulizing disease"
D.
Garcia-Olmos, Madrid P
"Molecular biology of azathioprine hepatotoxicity"
L.
Gonzalez-Guijarro, Madrid
P
"Advances in chip-technology in assessing prognosis of
complex disease" A. Martinez, Bilbao
P
"Synergy between medical informatics and bioinformatics:
facilitating genomic medicine for future health care"
F.
Martνn-Sanchez, Madrid P
11:50 12:10 Member
presentation
"Effect of anastomosis technique on
postoperative course of
CD"
R. McLeod P
12:10 13:10 Lunch
13:15- 14.15 Lunch in the Salon Primavera for partners and guests
13:10 15:10 Symposium I
"Cancer prevention in IBD"
Moderators: S. Hanauer
P,
A. Ekbom P
1. "Inflammation and cancer" C. Gaschι P
2. "Chemoprevention in ulcerative colitis" C. Bernstein P
3.
"Chemoprevention in ulcerative colitis /
PSC with UDCA" R. Loefberg
P
4. "Chemoprevention in Crohn's disease" J. Irvine P
15:10 15:40 IOIBD
Position statement on cancer prevention
J. Irvine P
15:40 Social program (departure by bus from visiting center (2 min walk from hotel) to Gredos Mountains, different down-hill walks to the valley, followed by dinner in the Parador of Gredos)
Saturday, April 21st
06:30 08:00 Foundation Board meeting (Salon Renacimiento)
09:15 16:30 Social program for partners and guests (visit to Pedraza, including lunch)
06:30 08:00 Breakfast (Salon Primavera: breakfast for partners and guests until 09.00)
08:00 08:30 Truelove
lecture:
Moderator: J. Schoelmerich
P
"Crohn's disease an immunodeficiency disorder?"
J.
Korzenik (Boston) P
08:30 10:00 Symposium
II
"The immune system: to much or to little lessons from biologicals"
Moderators: S. Schreiber P,
W. Sandborn P
1.
"Pharmacology and construction of antibodies used for
IBD" M. Clark
(Cambrigde) P
2.
"Relevance of immunogenicity in clinical practice"
P. Rutgeerts P
3.
"Tuberculosis and other infection complications with
biologicals" J.
Rhodes P
10:00 10:30 Coffee break
10:30 11:00 Senior
member lecture:
Moderator: J. Irvine P
"The GETAID history: an experience to set up a network for
clinical trials"
R. Modigliani P
11:00 12:30 Grant
reports (10 + 5)
"Genetic, immunologic, and serologic predictors of response
to anti TNF therapy in CD"
P. Rutgeerts (for S.
Vermeire) P
"Linkage disequilibrium mapping of the CD locus on
chromosome 19" D. Jewell (for D. McGovern)
"Postoperative management of CD with immediate vs.
delayed azathioprine" P. Rutgeerts (for G. van Assche)
"Genetic and environmental risk factors underlying
etiopathogenesis of IBD in India"
E. Seidman (for
D. Amre) P
"Evaluation of FODMAPS elimination diet to improve
diarrhea in ileal pouches" P.
Gibson P
"IOIBD multiplex families project"
J.F. Colombel (for C.
Tamboli) P
12:30 13:30 Task force meetings
13:30 14:30 Lunch (Salon Primavera)
13:30 14:30 Executive Committee meeting II (Salon Valle del Corneja)
14:30 15:30 Task Force
reports
Grant suggestions
15:30 18:00 Corporate
member presentations (15 + 5)
Moderators: J.F. Colombel
P, W. Sandborn
"Salofalk granules (3 g once a day vs 1 g TID) in active
ulcerative colitis" W. Kruis on behalf of Falk Pharma
P
"The emerging role of IL-21, a T cell-derived cytokine, in the
control of gut inflammation"
G. Monteleone (Rome) on behalf of Giulani S.p.A.P
"MMX Mesalamine: Extension study 303"
S. Hanauer on behalf of Shire Pharmaceuticals
P
"Long-term efficacy and safety results with Certolizumab
pegol in Crohn's disease"
S. Schreiber on behalf
of UCB P
"Escherichia
coli Nissle 1917 (EcN) as a guardian angel in
IBD" A. Sturm (Berlin) on behalf of Ardeypharm
P
"Budesonide
MMX, a novel highly efficient extended release formulation: phase II and
phase III studies in UC
G. D'Haens on behalf of Cosmo Pharmaceuticals
P
"Short- and long-term response with Visulizumab in IVSR
ulcerative colitis patients"
W. Sandborn on behalf of
PDL P
"An
Evaluation of Adalimumab on the Risk of Hospitalization in Patients with
Crohns Disease
"
W. Sandborn on behalf of
Abbott P
18:00 Concluding remarks J. Schoelmerich P
18:15 Time for individual walk through historic Avila; information on Avila will be in your hotel room on arrival
20:00 Gala Dinner (Patio)
Sunday, April 22nd
07:00 10:30 Breakfast and
Departure (transportation schedule to Madrid airport will be made available as well as posted in the lobby of the hotel)
Remarks: There will be 3 PC with wireless access and a printer available during the whole meeting to all members